NEVRAXIA
enfrdeit
contact@nevraxia.ch
Nevraxia Advisory02 / 02

Clinical and technology expertise for MedTech, industry and investors

Medical technology is judged, in the end, by clinicians in a real clinical environment. Nevraxia provides that judgement early — while a product is still being designed, positioned or evaluated.

01How to engage
01

Clinical Expert Services

One conversation with a senior clinician, when a question needs a practitioner rather than a report.

Format

30 to 90 minutes, remote. Written follow-up on request.

02

Clinical Reality Check

A structured assessment of a product against the way medicine is actually practised.

03

Clinical Product Advisory

Ongoing clinical input to a product, R&D or innovation team.

04

Due Diligence & Advisory Boards

Independent clinical review for investors, and medical boards convened around a question.

02The expert

  • Neurosurgeon · Engineer (EPFL)

  • Founder, Nevraxia

  • Medical Director, neurocentre – centre du dos, Lausanne

Areas of expertise

Neurosurgery, spine surgery, robotic surgery, surgical technologies, medical AI, clinical workflows and healthcare operations.

Advisory engagements are carried out independently through Nevraxia. Clinical affiliations are listed for professional verification and context.

03Services
0105

For consulting firms, expert networks, manufacturers and investors.

Format30 to 90 minutes, remote. Written follow-up on request.

A single conversation with a senior clinician, for consulting firms, expert networks, manufacturers and investors.

  1. 01

    Send the question and the context

  2. 02

    We confirm fit, availability and the absence of conflict

  3. 03

    A 30 to 90 minute call, remote

  • A clinical question that needs a practitioner rather than a literature search
  • A market, an indication or a patient pathway
  • A technology, and how it would actually be used
  • A clinical workflow, and who controls each step of it
0205
FormatWritten assessment with a review session. Typically two to four weeks.

A structured assessment of a product, prototype, medical device or AI system against the way medicine is actually practised — before or during development.

  • Clinical relevance, and the problem the product actually solves
  • Fit with the existing clinical workflow
  • Ergonomics and the real time cost per use
  • Likely adoption by physicians, and the barriers to it
  • Coherence between what the technology does and what practice requires
  • Weak points in the product as it stands
  • The questions clinicians and investors will ask, and how well they can currently be answered
0305
FormatRetained engagement, monthly or quarterly.

Ongoing clinical input to a product, R&D or innovation team, over the course of a development cycle.

  • Recurring sessions with the team
  • Review of roadmap decisions that carry clinical consequences
  • Feedback on specifications, interfaces and clinical claims
  • Preparation for discussions with clinicians and clinical sites
0405
FormatWritten report with a debrief. Timelines can follow a transaction process.

An independent clinical review of a technology or a company, for investors, funds, manufacturers and consulting firms.

  • Whether the clinical need is real, and who feels it
  • Clinical positioning against existing practice
  • Realistic adoption path, and who has to agree to it
  • Fit with clinical workflow, and the operational cost of that fit
  • Competitive landscape seen from clinical practice
  • Medical credibility of the team and of the claims made
  • Quality and defensibility of the clinical evidence
  • Clinical and regulatory risk
0505
FormatSingle sessions or a recurring board.

Participation in medical advisory boards, and the design and organization of new ones.

  • Participation as a clinical member
  • Definition of the questions a board should actually answer
  • Composition and recruitment of a panel of medical experts
  • Moderation, and a written record of what was decided

Nevraxia is building a network of medical experts across specialties, so that a board can be assembled around a specific question rather than around whoever is available.

04Who we work with

  • MedTech and Digital Health

    Founders, CEOs, CTOs, Chief Medical Officers, product managers and R&D teams.

  • Medical device manufacturers

    Companies bringing devices, implants or interventional systems into clinical use.

  • Medical AI companies

    Teams building clinical decision support, imaging, documentation or workflow systems.

  • Investors

    Venture capital, private equity and family offices evaluating healthcare technology.

  • Consulting firms and expert networks

    Firms that need a senior clinician for a specific client question or engagement.

Whether you want to automate clinical work, have a product examined by a practising clinician, or bring a senior medical perspective into an engagement — a short first conversation is usually enough to establish whether there is something to do.

Contact Nevraxiacontact@nevraxia.ch